Faro · $37.3M · Series B

Faro, a company developing AI tools for clinical trials, raised $37.3 million in Series B funding. The round was co-led by Merck Global Health Innovation Fund and S32. The funds will be used to speed up clinical trial timelines.

AI-generated: summaries written by AI from the linked sources. How we use AI